Term Name: | 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine |
---|---|
Synonyms: | (19R)-25-amino-22-hydroxy-22-oxido-16-oxo-17,21,23-trioxa-22lambda(5)-phosphapentacosan-19-yl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate, 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine, 1-Hexadecanoyl-2-docosahexanoyl-sn-glycero-3-phosphoethanolamine, 1-palmitoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine, 1-Palmitoyl-2-docosahexanoyl-sn-glycero-3-phosphoethanolamine, GPEtn(16:0/22:6), GPEtn(16:0/22:6n3), GPEtn(16:0/22:6w3), GPEtn(38:6), PE(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), PE(16:0/22:6), PE(16:0/22:6n3), PE(16:0/22:6w3), PE(38:6), Phophatidylethanolamine(38:6), Phosphatidylethanolamine(16:0/22:6), Phosphatidylethanolamine(16:0/22:6n3), Phosphatidylethanolamine(16:0/22:6w3) |
Definition: | A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl substituents at positions 1 and 2 are specified as hexadecanoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively. |
Ontology: | ChEBI [CHEBI:79097] ( EBI ) |